ETF Holdings Breakdown of BMEA

BMEA institutional holdings

The adjusted close for BMEA on 2025-11-11 was 1.40

The following institutional investment holdings of BMEA have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-11	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	44,567	USD 62,394 2.1%	1.40
2025-11-11	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	44,567	USD 62,394 2.1%	1.40
Total =		89,134	USD 124,788

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with BMEA

Biomea Fusion, Inc. (NASDAQ:BMEA) Receives $16.80 Consensus Price Target from Analysts

Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) have been given a consensus recommendation of “Buy” by the twelve ratings firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, eight have assigned a buy recommendation and three have assigned a strong buy […] - 2025-08-27 02:54:56

Biomea Fusion (NASDAQ:BMEA) Price Target Lowered to $7.00 at Citigroup

Biomea Fusion (NASDAQ:BMEA – Get Free Report) had its price target lowered by investment analysts at Citigroup from $9.00 to $7.00 in a research report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Citigroup’s target price suggests a potential upside of 324.24% from the company’s current price. Several other […] - 2025-08-13 02:46:43

Cwm LLC Purchases 16,681 Shares of Biomea Fusion, Inc. (NASDAQ:BMEA)

Cwm LLC grew its position in Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) by 8,058.5% in the first quarter, Holdings Channel.com reports. The fund owned 16,888 shares of the company’s stock after buying an additional 16,681 shares during the period. Cwm LLC’s holdings in Biomea Fusion were worth $36,000 as of its most recent filing […] - 2025-08-05 04:24:56

Biomea Fusion, Inc. (NASDAQ:BMEA) Receives $21.40 Average Price Target from Analysts

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) has received an average rating of “Buy” from the eleven ratings firms that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation, seven have given a buy recommendation and three have assigned a strong buy recommendation to the […] - 2025-06-13 02:32:52

Biomea Fusion (NASDAQ:BMEA) Stock Rating Upgraded by Piper Sandler

Piper Sandler upgraded shares of Biomea Fusion (NASDAQ:BMEA – Free Report) to a strong-buy rating in a report issued on Monday morning,Zacks.com reports. Several other research analysts have also commented on the company. Barclays dropped their price target on Biomea Fusion from $11.00 to $3.00 and set an “equal weight” rating for the company in […] - 2025-06-05 02:29:04

Two Sigma Advisers LP Increases Stock Holdings in Biomea Fusion, Inc. (NASDAQ:BMEA)

Two Sigma Advisers LP increased its holdings in Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) by 290.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 459,500 shares of the company’s stock after acquiring an additional 341,900 shares during the quarter. Two Sigma […] - 2025-05-30 05:30:50

Biomea Fusion, Inc. (NASDAQ:BMEA) Shares Acquired by Barclays PLC

Barclays PLC lifted its holdings in shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) by 18.4% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 46,904 shares of the company’s stock after acquiring an additional 7,284 shares during the period. Barclays PLC’s holdings in Biomea Fusion were worth $182,000 as of its most […] - 2025-05-13 04:36:51

Biomea Fusion, Inc. (NASDAQ:BMEA) Shares Bought by Renaissance Technologies LLC

Renaissance Technologies LLC boosted its holdings in Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) by 317.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 343,732 shares of the company’s stock after buying an additional 261,432 shares during the period. Renaissance Technologies LLC owned approximately 0.95% of Biomea […] - 2025-04-29 05:05:00

Biomea Fusion, Inc. (NASDAQ:BMEA) Receives $23.91 Average Target Price from Analysts

Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) have been given a consensus recommendation of “Buy” by the thirteen research firms that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, nine have given a buy recommendation and two have issued a […] - 2025-04-24 02:28:53

Federated Hermes Inc. Invests $463,000 in Biomea Fusion, Inc. (NASDAQ:BMEA)

Federated Hermes Inc. bought a new stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) in the fourth quarter, Holdings Channel reports. The fund bought 119,259 shares of the company’s stock, valued at approximately $463,000. Several other hedge funds also recently added to or reduced their stakes in BMEA. Wells Fargo & Company […] - 2025-04-18 04:57:03

Wellington Management Group LLP Invests $317,000 in Biomea Fusion, Inc. (NASDAQ:BMEA)

Wellington Management Group LLP purchased a new stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor purchased 81,759 shares of the company’s stock, valued at approximately $317,000. A number of other institutional investors also recently modified their holdings of BMEA. Barclays PLC raised […] - 2025-04-15 04:48:53

Reviewing Biomea Fusion (NASDAQ:BMEA) & Tango Therapeutics (NASDAQ:TNGX)

Biomea Fusion (NASDAQ:BMEA – Get Free Report) and Tango Therapeutics (NASDAQ:TNGX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation and institutional ownership. Valuation and Earnings This table compares Biomea […] - 2025-04-09 02:22:50

Analyzing Biomea Fusion (NASDAQ:BMEA) and Pliant Therapeutics (NASDAQ:PLRX)

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) and Biomea Fusion (NASDAQ:BMEA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Valuation and Earnings This table compares Pliant […] - 2025-03-28 04:08:52

Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of “Buy” from Analysts

Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) have earned a consensus rating of “Buy” from the thirteen ratings firms that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and two have given a strong buy recommendation […] - 2025-03-27 05:10:58

Biomea Fusion, Inc. (NASDAQ:BMEA) Receives $39.36 Average PT from Brokerages

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) has earned an average rating of “Buy” from the thirteen ratings firms that are covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the […] - 2025-03-05 04:20:51

Biomea Fusion, Inc. (NASDAQ:BMEA) Short Interest Up 6.2% in January

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) was the recipient of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 11,540,000 shares, a growth of 6.2% from the December 31st total of 10,870,000 shares. Based on an average trading volume of 891,600 shares, […] - 2025-02-03 04:10:56

Back to Listing

Disclaimer